Clinical Trials Sponsored by Pathfinder Therapeutics
Total 6342 results
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Corcept TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Ireland, Netherlands, Poland, Spain, United Kingdom
-
Aprea TherapeuticsCompletedAcute Myeloid Leukemia or Myelodysplastic SyndromesUnited States
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Chelsea TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Sage TherapeuticsCompletedEssential TremorUnited States
-
Northern TherapeuticsTerminated
-
UNION therapeuticsCompletedSkin Diseases | PsoriasisUnited Kingdom, Poland, United States, Germany
-
Transcend TherapeuticsEnrolling by invitationPost Traumatic Stress DisorderUnited Kingdom
-
PTC TherapeuticsCompletedFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Aligos TherapeuticsTerminatedChronic Hepatitis BNew Zealand, Bulgaria, Moldova, Republic of, Romania
-
PTC TherapeuticsCompletedLeiomyosarcomaUnited States
-
Fulcrum TherapeuticsTerminated
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Repare TherapeuticsActive, not recruitingAdvanced Solid TumorUnited States, Canada, Spain, United Kingdom
-
Spero TherapeuticsCompleted
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Aprea TherapeuticsCompletedHigh-grade Serous Ovarian CancerSpain, United Kingdom, Belgium
-
Lykos TherapeuticsNo longer availablePost Traumatic Stress DisorderUnited States
-
ONL TherapeuticsCompletedRhegmatogenous Retinal Detachment - Macula OffUnited States
-
Guided TherapeuticsEnrolling by invitationCervical DysplasiaUnited States
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
Chelsea TherapeuticsCompletedNeurogenic Orthostatic Hypotension | Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Neuropathy
-
Repare TherapeuticsActive, not recruitingAdult Solid TumorUnited States, Canada, United Kingdom
-
Lykos TherapeuticsTerminatedPosttraumatic Stress DisorderCanada
-
Lykos TherapeuticsEnrolling by invitationPTSDUnited States, Canada, Israel
-
Lykos TherapeuticsActive, not recruiting
-
Lykos TherapeuticsCompletedPosttraumatic Stress Disorder (PTSD)Israel
-
Lykos TherapeuticsWithdrawnPosttraumatic Stress Disorder
-
Lykos TherapeuticsCompletedPosttraumatic Stress DisorderUnited States
-
Lykos TherapeuticsCompletedPsychological Effects of Study DrugUnited States
-
Spark TherapeuticsActive, not recruitingConfirmed Biallelic RPE65 Mutation-associated Retinal DystrophyUnited States
-
CytomX TherapeuticsCompletedHead and Neck Cancer | Esophageal Cancer | Non Small Cell Lung Cancer | Diffuse Large B Cell Lymphoma | Solid Tumor, AdultUnited States, Spain, Korea, Republic of, United Kingdom
-
Spark TherapeuticsActive, not recruitingHemophilia AUnited States, Canada, Australia
-
RANI TherapeuticsCompletedHealthy VolunteersAustralia
-
PTC TherapeuticsCompletedPhenylketonuriaSpain, United States, Australia, Germany, United Kingdom, Brazil, Denmark, Canada, France, Georgia, Italy, Mexico, Netherlands, Portugal, Turkey
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
CytomX TherapeuticsTerminatedBreast Cancer | Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Solid Tumor, AdultUnited States, Spain, Netherlands, United Kingdom
-
United TherapeuticsCompletedPulmonary Arterial Hypertension
-
Intellia TherapeuticsTerminatedAcute Myeloid LeukemiaUnited States, United Kingdom
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
Akebia TherapeuticsCompletedAnemia Associated With Chronic Kidney Disease (CKD)United States
-
Karuna TherapeuticsCompletedSchizophrenia | Schizophrenia; PsychosisUnited States
-
PTC TherapeuticsCompletedLeigh SyndromeUnited States
-
Corcept TherapeuticsTerminatedMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
Fate TherapeuticsTerminatedLymphoma, B-Cell | Chronic Lymphocytic LeukemiaUnited States
-
Heron TherapeuticsActive, not recruitingAnalgesiaUnited States
-
Corcept TherapeuticsCompleted